Metraipolis › archive › dc_09ea280a04d2

Prostaglandin Pathway Polymorphisms and HsPDA Treatment Outcomes in Preterm Infants below 32 Weeks: Pilot Study — Europe PMC PMID:41300723

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41300723
DOI: 10.3390/genes16111271
License (as archived): solo-consultazione
Archived: 2026-11-08T23:57:17.202Z
SHA-256 of the archived text: 20ec758323abbbfeba31589821896b0fbdadc32bb815105e58a03c11161eabe4
Stable URL of this page: https://metraipolis.com/documento/dc_09ea280a04d2

How to cite

Prostaglandin Pathway Polymorphisms and HsPDA Treatment Outcomes in Preterm Infants below 32 Weeks: Pilot Study — Europe PMC PMID:41300723 — Europe PMC (en), https://europepmc.org/article/MED/41300723 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_09ea280a04d2 (Metraipolis archive dc_09ea280a04d2, sha256 20ec758323abbbfeba31589821896b0fbdadc32bb815105e58a03c11161eabe4)

BibTeX

@misc{dc09ea280a04d2,
  title = {Prostaglandin Pathway Polymorphisms and HsPDA Treatment Outcomes in Preterm Infants below 32 Weeks: Pilot Study — Europe PMC PMID:41300723},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41300723},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_09ea280a04d2; sha256 20ec758323abbbfeba31589821896b0fbdadc32bb815105e58a03c11161eabe4},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41300723. Agents can read the archived copy with the MCP tool read_document.